Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Sarclisa, isatuximab, Date of authorisation: 30/05/2020, Revision: 12, Status: Authorised

Regulation (EU) 2024/568: Questions and answers clinic for the Human Industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2025, 11:00 (CET) to 10 February 2025, 12:00 (CET)

Regulation (EU) 2024/568: Questions and answers clinic for the Human Industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 10 February 2025, 11:00 (CET) to 10 February 2025, 12:00 (CET)

Regulation (EU) 2024/568: Questions and answers clinic for the Veterinary Industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 15:00 (CET) to 11 February 2025, 16:00 (CET)

Regulation (EU) 2024/568: Questions and answers clinic for the Veterinary Industry stakeholders, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 February 2025, 15:00 (CET) to 11 February 2025, 16:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness